Abstract:Background: Disruptions in gamma-aminobutyric (GABA) acid signaling are believed to be involved in Huntington's disease pathogenesis, but the regulation of GABAergic signaling remains elusive. Here we evaluated GABAergic signaling by examining the function of GABAergic drugs in Huntington's disease and the expression of GABAergic molecules using mouse models and human brain tissues from Huntington's disease. Methods: We treated wild-type and R6/2 mice (a transgenic Huntington's disease mouse model) acutely with vehicle, diazepam, or gaboxadol (drugs that selectively target synaptic or extrasynaptic GABA(A) receptors) and monitored their locomotor activity. The expression levels of GABA(A) receptors and a major neuron-specific chloride extruder (potassium-chloride cotransporter-2) were analyzed by real-time quantitative polymerase chain reaction, Western blot, and immunocytochemistry. Results: The R6/2 mice were less sensitive to the sedative effects of both drugs, suggesting reduced function of GABA(A) receptors. Consistently, the expression levels of 1/2 and subunits were lower in the cortex and striatum of R6/2 mice. Similar results were also found in 2 other mouse models of Huntington's disease and in Huntington's disease patients. Moreover, the interaction and expression levels of potassium-chloride cotransporter-2 and its activator (brain-type creatine kinase) were decreased in Huntington's disease neurons. These findings collectively suggest impaired chloride homeostasis, which further dampens GABA(A) receptor-mediated inhibitory signaling in Huntington's disease brains. Conclusions: The dysregulated GABAergic responses and altered expression levels of GABA(A) receptors and potassium-chloride cotransporter-2 in Huntington's disease mice appear to be authentic and may contribute to the clinical manifestations of Huntington's disease patients. (c) 2017 International Parkinson and Movement Disorder Society

Hyperactivity and impaired attention in Gamma aminobutyric acid transporter subtype 1 gene knockout mice

Gamma Aminobutyric Acid Transporter Subtype 1 Gene Knockout Mice： a New Model for Attention Deficit/hyperactivity Disorder

Reduced Anxiety and Depression-Like Behaviors in Mice Lacking GABA Transporter Subtype 1

Reduced Aggression in Mice Lacking GABA Transporter Subtype 1.

Cognitive impairment in mice over-expressing gamma-aminobutyric acid transporter 1 (GAT1).

GABA Transporter-1 Deficiency Confers Schizophrenia-Like Behavioral Phenotypes

Cognitive impairment in mice over-expressing ??-aminobutyric acid transporter I (GAT1):

GABA transporter mGat4 is involved in multiple neural functions in mice

Mice with genetically altered GABA transporter subtype I (GAT1) expression show altered behavioral responses to ethanol.

Hypoalgesia in mice lacking GABA transporter subtype 1

Enhanced Learning and Memory in Gat1 Heterozygous Mice

Gaba Transporter-1 Activity Modulates Hippocampal Theta Oscillation And Theta Burst Stimulation-Induced Long-Term Potentiation

Homeostatic plasticity of GABAergic synaptic transmission in mice lacking GAT1.

[Ethanol Affects the Function of Gamma-Aminobutyric Acid Transporter I in Mice Brain].

Glutaminase C Overexpression in the Brain Induces Learning Deficits, Synaptic Dysfunctions, and Neuroinflammation in Mice.

Enhanced Glial Reaction and Altered Neuronal Nitric Oxide Synthase Are Implicated in Attention Deficit Hyperactivity Disorder

Reversible GABAergic dysfunction involved in hippocampal hyperactivity predicts early-stage Alzheimer disease in a mouse model

Altered behavioral responses to gamma-aminobutyric acid pharmacological agents in a mouse model of Huntington's disease.

Γ -Aminobutyric Acid Transporter (GAT1) Overexpression in Mouse Affects the Testicular Morphology

Lack of Cdk5 activity is involved on Dopamine Transporter expression and function: Evidences from an animal model of Attention-Deficit Hyperactivity Disorder

Synaptic scaling of corticostriatal circuits underlies hyperactivity in GABA Transporter-1 deficient mice